The company's principal activities are to develop and market medical products for therapeutic applications. The products of the company are designed to prevent or reduce the formation of adhesions (scar tissue) following a broad range of surgical procedures. These products are targeted to various segments in the medical community, including physicians, surgeons, and other care providers. The products repel, repel-cv, resolve and relieve are in various stages of development and prevent open heart, gynecological, orthopaedic and spinal surgeries.
